Article Details
Retrieved on: 2025-01-24 21:59:23
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses challenges in regenerative medicine, focusing on stem cell therapies. Frank Barry highlights inconsistencies in manufacturing and quality control affecting clinical trial outcomes, suggesting standardized protocols and improved quality criteria can enhance therapeutic consistency.
Article found on: www.bioprocessintl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here